CIK 0001133416
- Non-accelerated filer
- Smaller reporting company
GALECTIN THERAPEUTICS INC
Sign in to watch- Ticker
- GALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 043562325
- Phone
- +1 678-620-3186
- Business address
- 4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GA, 30071
- Former names
- PRO PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-10-13 | LEWIS JOEL President and CEO | Grant or award | +9,585 | $2.01 | $19K | 989,025 |
| 2023-10-13 | LEWIS JOEL President and CEO | Grant or award | +10,035 | $2.01 | $20K | 989,025 |
| 2023-09-29 | LEWIS JOEL President and CEO | Grant or award | +10,035 | $1.92 | $19K | 979,440 |
| 2023-09-26 | Uihlein Richard E Director | Exercise or conversion | +1,466,204 | $5.00 | $7.3M | 9,466,495 |
| 2023-09-26 | Uihlein Richard E Director | Exercise or conversion | +170,000 | $5.00 | $850K | 9,635,495 |
| 2023-09-26 | Uihlein Richard E Director | Exercise or conversion | +200,000 | $3.00 | $600K | 9,835,495 |
| 2023-09-26 | Uihlein Richard E Director | Exercise or conversion | +200,000 | $3.26 | $652K | 10,035,495 |
| 2023-09-26 | Uihlein Richard E Director | Exercise or conversion | +200,000 | $3.00 | $600K | 10,235,495 |
| 2023-09-26 | Uihlein Richard E Director | Exercise or conversion · Common Stock Purchase Warrant (right to buy) | −1,466,204 | 0 | ||
| 2023-09-26 | Uihlein Richard E Director | Exercise or conversion · Common Stock Purchase Warrant (right to buy) | −170,000 | 330,000 | ||
| 2023-09-26 | Uihlein Richard E Director | Exercise or conversion · Common Stock Purchase Warrant (right to buy) | −200,000 | 0 | ||
| 2023-09-26 | Uihlein Richard E Director | Exercise or conversion · Common Stock Purchase Warrant (right to buy) | −200,000 | 0 | ||
| 2023-09-26 | Uihlein Richard E Director | Exercise or conversion · Common Stock Purchase Warrant (right to buy) | −200,000 | 0 | ||
| 2023-09-15 | LEWIS JOEL President and CEO | Grant or award | +10,947 | $1.76 | $19K | 969,405 |
| 2023-08-31 | LEWIS JOEL President and CEO | Grant or award | +11,010 | $1.75 | $19K | 958,458 |
| 2023-08-15 | LEWIS JOEL President and CEO | Grant or award | +12,042 | $1.60 | $19K | 947,448 |
| 2023-07-31 | LEWIS JOEL President and CEO | Grant or award | +12,844 | $1.50 | $19K | 935,406 |
| 2023-07-19 | ELDRED KARY Director | Purchase | +1,598 | $1.79 | $3K | 48,813 |
| 2023-07-14 | LEWIS JOEL President and CEO | Grant or award | +11,820 | $1.63 | $19K | 922,562 |
| 2023-06-30 | LEWIS JOEL President and CEO | Grant or award | +13,380 | $1.44 | $19K | 910.74 |
Page 16 of 21 · 404 trades